US$ 28.75
bpc-157 safety regulatory status Legal Status: FDA Regulations and Compounding bpc-157 human clinical trials evidence
Description
In one model, systemic administration of the peptide BPC-157 significantly promoted muscle healing, suggesting its potential to enhance recovery outcomes following muscle injuries

Users with metabolic syndrome or insulin resistance often see the earliest improvements

doi: 10.1210/jc.2018-00070

AOD9604 is a synthetic peptide fragment used in laboratory research to study metabolic signaling, adipose tissue biology, and related experimental models

Adenosine receptor blockade and nitric oxide synthase inhibition in the retina: Impact upon post-ischemic hyperemia and the electroretinogram